Broadridge Financial Solutions, Inc. (BR) is down 5.3% today. Here is some analysis on what might have caused this price movement.
Analysis: The selloff appears tied to a mixed reaction to Broadridge’s fiscal third-quarter update: profit metrics and full-year earnings growth guidance improved, but the company reduced its full-year closed-sales outlook and showed some margin pressure. Investors may be treating the lower closed-sales range as a signal that large, complex deals are taking longer to convert into signed contracts.
Details:
Sources:
Broadridge Investor Relations, SEC, The Motley Fool
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$BR Insider Trading Activity
$BR insiders have traded $BR stock on the open market 6 times in the past 6 months. Of those trades, 1 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $BR stock by insiders over the last 6 months:
- THOMAS P CAREY (Corporate VP) has made 0 purchases and 3 sales selling 10,214 shares for an estimated $2,341,617.
- TIMOTHY C GOKEY (CEO) purchased 5,300 shares for an estimated $1,030,794
- CHRISTOPHER JOHN PERRY (President) sold 3,984 shares for an estimated $900,384
- ROBERT N DUELKS sold 253 shares for an estimated $48,727
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
$BR Hedge Fund Activity
We have seen 463 institutional investors add shares of $BR stock to their portfolio, and 559 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 3,354,964 shares (-76.7%) from their portfolio in Q4 2025, for an estimated $748,727,315
- NORGES BANK added 1,042,297 shares (+204.6%) to their portfolio in Q4 2025, for an estimated $232,609,421
- VAN ECK ASSOCIATES CORP added 774,747 shares (+110.6%) to their portfolio in Q4 2025, for an estimated $172,900,287
- MACQUARIE GROUP LTD removed 658,130 shares (-96.5%) from their portfolio in Q4 2025, for an estimated $146,874,872
- APG ASSET MANAGEMENT N.V. removed 610,126 shares (-40.8%) from their portfolio in Q4 2025, for an estimated $136,161,819
- AMERIPRISE FINANCIAL INC added 538,305 shares (+43.4%) to their portfolio in Q4 2025, for an estimated $120,133,526
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 528,736 shares (-55.6%) from their portfolio in Q4 2025, for an estimated $117,998,013
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
$BR Congressional Stock Trading
Members of Congress have traded $BR stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $BR stock by members of Congress over the last 6 months:
- REPRESENTATIVE RICK LARSEN sold up to $15,000 on 04/07.
- REPRESENTATIVE DAN NEWHOUSE purchased up to $15,000 on 12/31.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.
$BR Price Targets
Multiple analysts have issued price targets for $BR recently. We have seen 5 analysts offer price targets for $BR in the last 6 months, with a median target of $250.0.
Here are some recent targets:
- Peter Heckmann from DA Davidson set a target price of $228.0 on 04/22/2026
- Kyle Peterson from Needham set a target price of $255.0 on 04/06/2026
- Puneet Jain from JP Morgan set a target price of $229.0 on 02/04/2026
- Alex Kramm from UBS set a target price of $250.0 on 11/13/2025
- James Faucette from Morgan Stanley set a target price of $256.0 on 11/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.